Navigation Links
Pioneer® Surgical Technology, Inc. Enters the Biologics Extremities and Pelvis Market
Date:3/8/2011

RALEIGH, N.C., March 8, 2011 /PRNewswire/ -- Pioneer Surgical Technology today announces the market launch of their new portfolio of biologic products, designed to be used in extremities and pelvis.

The new portfolio will be showcased during the 2011 American College of Foot and Ankle Surgeons (ACFAS) convention in Fort Lauderdale this week. Pioneer Surgical Technology’s newest Biologics product, Legato™, will be included. Legato is a resorbable, collagen-based implant that acts as a scaffold for the in-growth of new bone and is designed to have broad appeal in repairing bony defects in the extremities and pelvis, including those caused by trauma. In addition, Legato forms a cohesive and adhesive product easily shaped to defects while maximizing direct contact with host bone.

Regarding Pioneer’s latest product introduction Mr. Shane Ray, General Manager – Biologics for Pioneer stated, “We are very pleased to expand our product offerings with Legato into the extremities, trauma and general othopaedics market. Our goal has always been to establish highly effective products first in spine and now expanding into additional high growth markets such as extremities. We saw incredible sales growth in 2010 and are executing our 2011 growth plans to expand our product offerings within and outside the United States.”

For more information regarding Pioneer’s Biologics Foot and Ankle offerings including Legato, please visit the Pioneer Surgical website at www.pioneersurgical.com.

About Pioneer Surgical Technology, Inc.

Pioneer Surgical Technology, Inc. is a dynamic medical device firm founded in 1992. Pioneer’s focus on innovation has resulted in over 120 U.S. and foreign patents, with numerous patents pending. The company has a comprehensive portfolio of orthopaedic, spine and biologic systems. Pioneer entered the orthobiologics market with two acquisitions in 2007. Our Orthopaedic, Spine, and Biologics divisions produce state of the art, cost-effective solutions for surgical procedures that have proven difficult or problematic for both surgeons and patients. Pioneer employs more than 270 people worldwide. For more information on Pioneer and its products, visit www.pioneersurgical.com.


'/>"/>
SOURCE Pioneer Surgical Technology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Baxter Announces Licensing Agreement for Innocolls Gentamicin Surgical Implant in the United States
2. Solos Endoscopy, Inc. Implements Strategy to Capitalize on $30 Billion Minimally Invasive Surgical Product Market
3. Sound Surgical Technologies Welcomes Dr. Mark Schafer as New Chief Technology Officer and Vice President of Research & Development
4. New Opportunities in X-Ray Based Surgical Navigation With Ziehm NaviPort 3D
5. Reliant Technologies Announces FDA 510(K) Clearance of New Handpieces for Skin Resurfacing and Surgical Applications
6. CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure
7. Pioneer(R) Surgical Technology Announces Market Release of FortrOss(TM), a Next Generation Bone Void Filler
8. Pioneer(R) Surgical Technology Announces First Human Implants of New nanOss(TM)-Cervical Fusion Device
9. PEAK Surgical Introduces PlasmaBlade(TM) Product Line Extensions for Use in General Surgery
10. Starch Medical Launches New, Bioinert Surgical Hemostats
11. Minimally Invasive Surgery: Olympus Further Enhances Credentials by Entering Into Exclusive Sales and Distribution Partnership With Market and Technology Leader Advanced Surgical Concepts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... January 21, 2017 , ... ... bring to market a pioneering medical device for the treatment of Age-Related Macular ... contract with Emergo, a global regulatory consultancy that helps companies like ours secure ...
(Date:1/21/2017)... 20, 2017 Bioptix, Inc. (Nasdaq: ... that on January 14, 2017 the Board of Directors ... Company will terminate certain employees associated with the September ... Company commenced terminations on January 16, 2017 and terminations ... Company may pay severance benefits in certain circumstances of ...
(Date:1/21/2017)... Mass. , Jan. 21, 2017   Boston ... novel compounds designed to target cancer stemness pathways, today ... investigational compound, napabucasin, at the 2017 American Society of ... San Francisco . In a ... investigational agent designed to inhibit cancer stemness pathways by ...
(Date:1/20/2017)... 2017 Stock-Callers.com explores the Biotech ... the most recent performances of select equities. In this ... RGLS ), Abeona Therapeutics Inc. (NASDAQ: ABEO ... and Sage Therapeutics Inc. (NASDAQ: SAGE ). ... Research, global Biotech market size is expected to reach $604.40 billion by 2020 ...
Breaking Biology Technology:
(Date:1/11/2017)... MOINES, Iowa , Jan. 11, 2017 ... industry first with the release of its patent-pending calibration ... quickly and reliably perform calibrations, securely upload data logs ... flexibility for the customer. "Fighting drunk driving ... only for the public at large, but also for ...
(Date:1/6/2017)...  SomaLogic announced today that it has agreed ... iCarbonX, the China -based company ... Health Ecosystem that can define each person,s ,digital ... behavioral and psychological data, the Internet and artificial ... will provide proteomics data and applications expertise to ...
(Date:1/4/2017)... 4, 2017  CES 2017 – Valencell , ... today announced the launch of two new versions ... highly-accurate biometric sensor modules that incorporate the best ... and expertise. The two new designs include Benchmark ... hearables, and Benchmark BW2.0, a 2-LED version of ...
Breaking Biology News(10 mins):